Total raised
—
Last: Seed 2017-01
Stage
Seed
Founded
2016
Headcount
1-10
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
Mydimed develops algorithms and software tools designed to help prevent adverse drug reactions (ADR) among high-risk, poly-pharmacy patients. The company utilizes artificial intelligence and proprietary algorithms that derive insights from medical records and help predict and prevent morbidity and mortality. Mydimed's technology is based on medical research and advanced data science, a powerful combination that yields better prediction results by analyzing electronic medical records and derivatives of electronic medical records to obtain an optimal approximation for the prediction of high-risk ADRs that can lead to hospitalization or readmission.
Funding history · 1 round · — total
2017-01
Seed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticalsConsumersDemographics & FamilySeniors
Business model
B2B2CB2B
Highlights
Verified
Tags
algorithmspredictive-analyticsbig-datapharma-companieshealthcare-providersartificial-intelligencemachine-learningdata-analyticsrisk-managementseniorssafetymedicationhealth-informationdigital-healthcaredecision-supportemr